| 产品名称： | Actinosynnema pretiosum subsp. auranticum Hasegawa et al. |
|---|---|
| 商品货号： | TS190883 |
| Deposited As： | Nocardia sp. |
| Strain Designations： | N-1231 FERM-P 5185, IFO 13963 |
| Application： | Produces C-15003 PHM Produces maytansinoids Produces antitumor and antiprotozoal agents C-15003 PHM and other maytansinoids |
| Isolation： | Mutant derived from ATCC 31309 |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Takeda Chem. Ind., Ltd. |
| U.S. Patent Number： | |
| References： | Izawa M, et al. Maytansinoids. US Patent 4,331,598 dated May 25 1982 Izawa M, et al. Antibiotic C-15003 PHM and production thereof. US Patent 4,450,234 dated May 22 1984 |
| Cross References： | Nucleotide (GenBank) : AF056968 Actinosynnema pretiosum auranticum DAHP synthase (aroF) gene, complete cds. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Actinosynnema pretiosum subsp. auranticum Hasegawa et al. |
|---|---|
| 商品货号： | TS190883 |
| Deposited As： | Nocardia sp. |
| Strain Designations： | N-1231 FERM-P 5185, IFO 13963 |
| Application： | Produces C-15003 PHM Produces maytansinoids Produces antitumor and antiprotozoal agents C-15003 PHM and other maytansinoids |
| Isolation： | Mutant derived from ATCC 31309 |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Takeda Chem. Ind., Ltd. |
| U.S. Patent Number： | |
| References： | Izawa M, et al. Maytansinoids. US Patent 4,331,598 dated May 25 1982 Izawa M, et al. Antibiotic C-15003 PHM and production thereof. US Patent 4,450,234 dated May 22 1984 |
| Cross References： | Nucleotide (GenBank) : AF056968 Actinosynnema pretiosum auranticum DAHP synthase (aroF) gene, complete cds. |
